Fan Z, Tardif G, Hum D, Duval N, Pelletier J-P, Martel-Pelletier J
University of Montreal Hospital Centre, Notre-Dame Hospital, Quebec, Canada.
Ann Rheum Dis. 2009 Jun;68(6):976-82. doi: 10.1136/ard.2008.092288. Epub 2008 Jul 1.
Human osteoarthritic (OA) chondrocytes were previously classified into L (low)- and H (high)-OA according to matrix metalloproteinase-13 (MMP-13) basal levels and interleukin 1beta (IL1beta) inducibility. In H-OA chondrocytes, the regulatory proteins p130(cas) and nuclear matrix protein 4 (NMP4) acting on the MMP-13 promoter were identified.
To identify regulators of MMP-13 expression/production in human L-OA chondrocytes, to determine their effect on the expression of other MMPs and the effect of IL1beta on these molecules.
The identification of the L-OA chondrocyte proteins interacting specifically with the AGRE site of the MMP-13 promoter was performed by mass spectrometry. Heat shock protein 90beta (Hsp90beta), p130(cas) and NMP4 small interfering RNAs (siRNAs) were transfected into L-OA chondrocytes and incubated with or without IL1beta. Gene expression was determined by real-time PCR, MMP-1 and MMP-13 production by ELISA, and signalling pathway activation by western blotting and ELISA.
Hsp90beta was identified as a protein of the L-OA/AGRE-specific complex. Silencing p130(cas) and Hsp90beta significantly increased MMP-13 expression (about four- and twofold, respectively) and production. sip130(cas) affected to a lesser extent MMP-1 expression (twofold) and production. siNMP4 showed no effect. Expression of MMP-2, -3, -9 and -14 was unaffected. Silencing both Hsp90beta and p130(cas) had a significant additive effect on MMP-13, but not on MMP-1 expression, the level of which was similar to that with sip130(cas) alone. IL1beta decreased p130(cas) and Hsp90beta expression/production, indicating another pathway by which this cytokine upregulates MMP expression. The IL1beta-triggered signalling pathways responsible for MMP upregulation were unaffected in the silenced cells.
This study illustrates the complex regulation of MMP-13 by showing the inhibitory effect of the two cytoplasmic molecules, p130(cas) and Hsp90beta, in L-OA chondrocytes.
人骨关节炎(OA)软骨细胞先前根据基质金属蛋白酶-13(MMP-13)基础水平和白细胞介素1β(IL1β)诱导性被分为L(低)-OA和H(高)-OA。在H-OA软骨细胞中,已鉴定出作用于MMP-13启动子的调节蛋白p130(cas)和核基质蛋白4(NMP4)。
鉴定人L-OA软骨细胞中MMP-13表达/产生的调节因子,确定它们对其他基质金属蛋白酶(MMPs)表达的影响以及IL1β对这些分子的影响。
通过质谱法鉴定与MMP-13启动子的AGRE位点特异性相互作用的L-OA软骨细胞蛋白。将热休克蛋白90β(Hsp90β)、p130(cas)和NMP4小干扰RNA(siRNAs)转染到L-OA软骨细胞中,并在有或无IL1β的情况下孵育。通过实时PCR测定基因表达,通过酶联免疫吸附测定(ELISA)测定MMP-1和MMP-13产生,并通过蛋白质印迹法和ELISA测定信号通路激活。
Hsp90β被鉴定为L-OA/AGRE特异性复合物的一种蛋白质。沉默p130(cas)和Hsp90β显著增加MMP-13表达(分别约为四倍和两倍)和产生。sip130(cas)对MMP-1表达(两倍)和产生的影响较小。siNMP4无作用。MMP-2、-3、-9和-14的表达未受影响。同时沉默Hsp90β和p130(cas)对MMP-13有显著的累加效应,但对MMP-1表达无累加效应,MMP-1表达水平与单独使用sip130(cas)时相似。IL1β降低p130(cas)和Hsp90β的表达/产生,表明该细胞因子上调MMP表达的另一条途径。在沉默的细胞中,IL1β触发的负责MMP上调的信号通路未受影响。
本研究通过显示两种细胞质分子p130(cas)和Hsp90β在L-OA软骨细胞中的抑制作用,阐明了MMP-13的复杂调节。